Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective.